Vaccines Market - Forecast(2021 - 2026)

Report Code: HCR 0711 Report Format: PDF + Excel (Delivery in 48 Hrs)

Vaccines Market Overview

Vaccines Market size is estimated to be $39,444 Million in 2019, growing at a CAGR of 8.4% during the forecast period 2020-2025. According to the Centers for Disease Control and Prevention “a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease”. In addition, vaccines are usually administered through needle injection, through mouth or sprayed into the nose. The rising number of people suffering from various Infectious diseases has led to the increased adoption of vaccines around the world which in turn is fostering its market growth. Apart from this, the sudden covid-19 has created a pandemic which has exerted immense pressure on the pharmaceutical companies to a develop vaccines against it. Hence, the companies are adopting different strategies such as collaboration and expansion to accelerate the rapid development of covid-19 vaccine. For instance, in April 2020, Sanofi and GSK collaborated to develop an Adjuvanted vaccine for covid-19, using innovative technology from both companies to help address the ongoing pandemic. Apart from this, the various government funding towards development of new vaccines is also contributing to its market growth. For instance, in November 2020 the finance minister of India announced a rupees 900 crore stimulus towards research and development of covid-19 vaccine and also assuring that the funds would be provided according to the requirement for the cost of vaccines and logistics requirements as well in future.

Report Coverage

The report: “Vaccines Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Vaccines Market.
By Vaccines Valence - Monovalent and Multivalent.
By Vaccines Type - Live Attenuated Vaccines, Inactivated & Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines and Other.
By Disease Indication - Bacterial Diseases and Viral Diseases.
By Route of Administration - Intramuscular, Subcutaneous, Oral and Other.
By End-User - Adults and Pediatrics.
By Distribution Channel - Hospital & Retail Pharmacies, Government Suppliers and Other.
By Geography - North America, Europe, Asia Pacific and Rest of the World.

Key Takeaways

  • Multivalent segment held the largest market share in the year 2019 owing to the increasing prevalence of rare infectious disease and enormous government initiatives towards immunization is a significant factor contributing to its segmental growth.
  • Intramuscular segment held the largest market share in the year 2019 owing to the ease of supplying larger amount of drug or fluid in the muscles.
  • North America contributed to the largest market share of 39.2% in 2019 owing to increasing government initiatives for monitoring vaccine safety and conducting research on vaccine safety.
  • The increasing number of merger & acquisition in vaccine industry with an aim to develop new product is a significant factor driving the Vaccines market during the forecast period 2020-2025.

Vaccines Market Segment Analysis - By Vaccines Valence

By Vaccines Valence, the Vaccines Market is segmented into Monovalent and Multivalent. Multivalent segment held the largest market share in the year 2019 owing to the increasing prevalence of rare infectious disease and enormous government initiatives towards immunization is a significant factor contributing to its segmental growth. Moreover, according to the Center for Disease Control and Prevention four variants of meningococcal vaccines are used by the United States. On the basis of type two vaccines used are recombinant monovalent protein vaccine, which provide protection against serogroup B antigen. Owing to these benefits of protection against meningococcal serogroup B to age group 16-23 years is eventually leading to an increase in its revenue. Also, Multivalent, is projected to witness growth at fastest CAGR of 9.2% in forecast period 2020-2025. On September 2020, ProMIS Neursciences Inc. a biotechnology firm announced its development of multivalent vaccine for Alzheimer disease through advance technology which is set to develop vaccine against amyloid beta toxic oligomers (ABOs). ABO are the main causing agent for alzheimer, for this ProMIS has successfully conducted pre-clinical trial on mice with its one of the identified peptide epitopes against ABO.

Vaccines Market Segment Analysis - By Route of Administration

By Route of Administration, the Vaccines Market is segmented into Intramuscular, Subcutaneous, Oral and Others. Intramuscular segment held the largest market share in the year 2019 owing to the ease of supplying larger amount of drug or fluid in the muscles. An intramuscular injection is a technique used to deliver a medication deep into the muscles which allows the medication to be absorbed into the bloodstream quickly. Moreover, depending on the patient’s age, intramuscular injections are delivered at 90-degree angle to the skin, preferably into the anterolateral part of the thigh or the deltoid muscle of the upper arm. Also, subcutaneous, is projected to witness growth at CAGR of 7.1% in forecast period 2020-2025. A subcutaneous is a process of delivering medicine under the skin. In this type of route of administration, a small needle is used to inject a drug into the tissue layer between the skin and muscle. In addition, since there are few blood vessels in subcutaneous tissue, the injected drug is distributed very slowly at a sustained rate of absorption. Therefore, the administration of vaccines, growth hormones and insulin requiring continuous delivery at a low dose rate is highly successful. 

Vaccines Market Segment Analysis - Geography

North America contributed to the largest market share of 39.2% in 2019 owing to increasing government initiatives for monitoring vaccine safety and conducting research on vaccine safety. Moreover, in U.S. the Centers for Disease Control and Prevention is responsible for childhood immunization. The schedule for vaccination is broken down by age: birth to six years of age, seven to eighteen years of age and nineteen and older adults. Besides this, in 2019 Mexico has been considered a regional immunization pioneer. For instance, AstraZeneca would manufacture 150 million doses of covid-19 vaccine in early 2021, in collaboration with the government of Mexico and Argentina, and would eventually make at least 400 million doses available for distribution in Latin America. 

Vaccines Market Drivers

Increasing Number of Merger & Acquisition in Vaccine Industry, with An Aim to develop New Product

The increasing number of merger & acquisition in vaccine industry with an aim to develop new product is a significant factor driving the Vaccines market during the forecast period 2020-2025. With the ongoing pandemic major manufacturers have adopted different strategies including merger, acquisition for the development of vaccines which is eventually contributing to its market growth. For instance, in April 2020 AstraZeneca collaborated with the University of Oxford with an aim to bring to patients the potential vaccine known as Chadox1 nCov-19, being developed by the Jenner Institute and Oxford Vaccine Group, at the University of Oxford.

Increasing Government Initiatives for Immunization

Increasing government initiatives for immunization is a major factor driving the Vaccines Market during the forecast period 2020-2025. According to World Health Organization, immunization saves millions of lives and is widely recognized as one of the world’s most successful and cost-effective health interventions. In addition, vaccines save 3 million lives each year worldwide from infectious disease including hepatitis, diphtheria, tetanus, pertussis, measles and polio which in turn is boosting its market growth. Moreover, increasing government initiatives to create more awareness regarding vaccination is another factor contributing to its market growth. For instance, in Romania according to vaccination law parents who don’t get their kids vaccinated and keep them out of school need to pay a fine. According to this law doctors can be fined as well.

Vaccines Market Challenges

High Cost from Development to Compliance of Vaccines

High Cost from development to compliance of vaccines serves as a major setback for the growth of the Vaccines Market during the forecast period 2020-2025. Besides this, stringent rules and regulations regarding the efficiency of vaccines is restraining its market during the forecast period 2020-2025.

Vaccines Market Industry Outlook

Product Launches, Merger & Acquisition, joint ventures and R&D activities are key strategies adopted by the players in Vaccines Market. Vaccines Market top 10 are Serum Institute of India Pvt. Ltd, Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson, CSL Limited, Emergent Biosolutions Inc., AstraZeneca, GlaxoSmithKline, Sanofi, Merck & Co Inc., and Pfizer Inc.

Developments:

  • July 2020: Moderna and Catalent collaborated for large-scale commercial fill-finish manufacturing of Moderna’s Mrna based covid-19 vaccine candidate at Catalent’s biologics facility in Bloomington, Indiana.

1. Vaccines Market Overview
    1.1 Definitions and Scope
2. Vaccines Market - Executive Summary
    2.1 Market Revenue, Market Size and Key trends 
    2.2 Key trends by Vaccines Valence
    2.3 Key trends by Vaccines Type
    2.4 Key trends by Disease Indication
    2.5 Key trends by Route of Administration
    2.6 Key trends by Distribution Channel
    2.7 Key trends by Geography
3. Vaccines Market –Comparative Analysis
    3.1 Product Benchmarking - Key companies
    3.2 Financials Analysis - Key Companies
    3.3 Market Share Analysis- Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis- Average Selling Price
4. Vaccines Market- Startup companies Scenario Premium Premium 
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Vaccines Market – Industry Market Entry Scenario Premium Premium 
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Vaccines Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Vaccines Market -Strategic analysis
    7.1 Value chain analysis 
    7.2 Opportunities analysis
    7.3 Market life cycle
8. Vaccines Market – By Vaccines Valence (Market Size – $Million/$Billion)
    8.1 Monovalent
    8.2 Multivalent
9. Vaccines Market – By Vaccines Type(Market Size – $Million/$Billion)
    9.1 Live Attenuated Vaccines
    9.2 Inactivated and Subunit Vaccines
    9.3 Toxoid Vaccines
    9.4 Conjugate Vaccines
    9.5 Recombinant Vaccines
    9.6 Travel Vaccines
    9.7 Others
10. Vaccines Market – By Disease Indication (Market Size – $Million/$Billion)
    10.1 Bacterial Diseases
        10.1.1 Pneumococcal Disease
        10.1.2 Diphtheria
        10.1.3 Tetanus
        10.1.4 Pertussis
        10.1.5 Meningococcal Disease
        10.1.6 Tuberculosis
        10.1.7 Others
    10.2 Viral Diseases
        10.2.1 Human Papilloma Virus
        10.2.2 Polio
        10.2.3 Encephalitis
        10.2.4 Yellow Fever
        10.2.5 Rotavirus
        10.2.6 Hepatitis
        10.2.7 Measles
        10.2.8 Mumps
        10.2.9 Rubella
        10.2.10 Varicella
        10.2.11 Coronavirus
        10.2.12 Others
11. Vaccines Market – By Route of Administration(Market Size – $Million/$Billion)
    11.1 Intramuscular (IM)
    11.2 Subcutaneous (SC)
    11.3 Oral
    11.4 Other
12. Vaccines Market – By End-User(Market Size – $Million/$Billion)
    12.1 Adults
    12.2 Pediatrics
13. Vaccines Market – By Distribution Channel(Market Size – $Million/$Billion)
    13.1 Hospital & Retail Pharmacies
    13.2 Government Suppliers
    13.3 Others
14. Vaccines Market - By Geography (Market Size - $Million/$Billion)
    14.1 North America
        14.1.1 U.S.
        14.1.2 Canada
        14.1.3 Mexico
    14.2 Europe
        14.2.1 U.K.
        14.2.2 Germany
        14.2.3 France
        14.2.4 Italy
        14.2.5 Spain
        14.2.6 Netherland
        14.2.7 Rest of Europe
    14.3 Asia-Pacific
        14.3.1 China
        14.3.2 Japan
        14.3.3 South Korea
        14.3.4 India
        14.3.5 Australia & New Zealand
        14.3.6 Rest of APAC
    14.4 Rest of the World
        14.4.1 Middle East
        14.4.2 Africa
        14.4.3 South America
15. Vaccines Market - Entropy
16. Vaccines Market – Industry/Segment Competition Landscape Premium 
    16.1 Market Share Analysis
        16.1.1 Global Market Share – Key Companies
        16.1.2 Market Share by Region – Key companies
        16.1.3 Market Share by Country- Key companies
        16.1.4 Best Practices for Companies
17. Vaccines Market – Key Company List by Country Premium Premium
18. Vaccines Market Company Analysis
    18.1 Company Revenue, Products, M&A, Developments
    18.2 Serum Institute Of India Pvt. Ltd
    18.3 Mitsubishi Tanabe Pharma Corporation
    18.4 Johnson & Johnson
    18.5 CSL Limited
    18.6 Emergent Biosolutions Inc.,
    18.7 AstraZeneca
    18.8 Glaxo SmithKline
    18.9 Sanofi
    18.10 Merck & Co Inc.,
    18.11 Pfizer Inc.,
*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1 Global Vaccines Market, Key Vaccines by Country, 2018
Table 2 Global Vaccines Market Revenue ($m), By Company, 2018
Table 3 Global Vaccines Market Competitor Benchmarking
Table 4 Major Government Regulations 
Table 5 The Ease of Doing Business Index: Top Countries
Table 6 Global Vaccines Market: Children aged 19-35 months receiving vaccinations in U.S. (%), 2018
Table 7 Vaccines Market, Key Company List by Key Country, 2018
Table 8 Assumptions & Research Methodology for Global Vaccines Market
Table 9 Secondary Sources: Global Vaccines Market (Partial List)
Table 10 Primary Sources: Global Vaccines Market (Partial List)


List of Figures

Figure1 Global Vaccines Market, PESTLE Analysis
Figure2 Global Vaccines Value share - By Geography 2018, 2023 (%)
Figure3 Global Vaccines Market CAGR (%) – By Geography 
Figure4 Global Vaccines Value share - By Technology 2018, 2023 (%)
Figure5 Global Vaccines Market CAGR (%) – By Technology
Figure6 Pfizer Inc.
Figure7 Merck & Co., Inc.
Figure8 GlaxoSmithKline plc
Figure9 Sanofi
Figure10 CSL Limited
Figure11 EPS, By Company, 2015-2018 ($/Share)
Figure12 Global Human Vaccines Market, Number of Patents, 2014 – 2019*
Figure13 Global Human Vaccines Market, Number of Patents, By Country, 2014 – 2018*
Figure14 Global Vaccines Market, Market Share, By Company, 2018 (%)
Figure15 Global Vaccines Market Startup Investment, 2014 – March* 2019, ($Million)
Figure16 Global Vaccines Market Investment Share, By Company (Startup) (%)
Figure17 Global Vaccines Market, Value Chain Analysis
Figure18 Figure: Global Vaccines Market Life Cycle, 2018–2023
Figure19 Global Vaccines Market Segmentation – By Technology
Figure20 Global Vaccines Market Growth Rate- By Technology, 2018–2023 (%)
Figure21 Global Vaccines Market Segmentation – By Disease Indication
Figure22 Global Vaccines Market Growth Rate- By Disease Indication, 2018–2023 (%)
Figure23 Global Vaccines Market Segmentation – By End User
Figure24 Global Vaccines Market Growth Rate- By End user, 2018–2023 (%)
Figure25 Global Vaccines Market Entropy Share, By Strategies, 2016--2019* (%)
Figure26 Global Vaccines Market Entropy, By Total Number of Developments, 2016-2019*